Univar BV: Clinical Trials

3 trials sponsored by Univar BV, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 unknown. 1 Phase 1, 1 Phase 2, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Completed 1
Phase 41Unknown 1

Follow Univar BV: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Efficacy and Mechanism of Trientine in Patients With Hypertrophic Cardiomyopathy
Trientine, Placebo - Hypertrophic Cardiomyopathy
Phase 2CompletedManchester University NHS Foundation Trust1542020-12-012025-09-29
Study to Assess Long-Term Outcomes of Trientine in Wilson Disease Patients Withdrawn From Therapy With d-Penicillamine
trientine dihydrochloride - Wilson Disease
Phase 4UnknownUnivar BV902016-01-012017-08-23
A Phase 1 Study to Assess the Effects in the Body of a Single Dose of Trientine Dihydrochloride in Wilson's Disease Patients
trientine dihydrochloride - Wilson's Disease
Phase 1CompletedUnivar BV202013-05-012014-09-19

Conditions studied

Hepatolenticular Degeneration (2)  ·  Cardiomyopathy, Hypertrophic (1)

Interventions

Trientine (3)

Countries

Germany (2)  ·  United Kingdom (2)  ·  Greece (1)  ·  Italy (1)

Top investigators

Chris Miller (1)  ·  Karl-Heinz Weiss, MD (1)

Results publications

PMID 35482910, PMID 37137675, PMID 40104015, PMID 42455121